Porton Pharma Solutions Ltd
SZSE:300363
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Porton Pharma Solutions Ltd
SZSE:300363
|
CN |
|
Sight Sciences Inc
NASDAQ:SGHT
|
US |
|
H
|
Hunan Valin Steel Co Ltd
SZSE:000932
|
CN |
|
Infore Environment Technology Group Co Ltd
SZSE:000967
|
CN |
|
Gps Participacoes e Empreendimentos SA
BOVESPA:GGPS3
|
BR |
|
T
|
Tongxing Environmental Protection Technology Co Ltd
SZSE:003027
|
CN |
|
A
|
Agro Phos India Ltd
NSE:AGROPHOS
|
IN |
|
World Financial Holding Group
OTC:WFHG
|
US |
|
iSun Inc
OTC:ISUNQ
|
US |
|
Diversified Royalty Corp
TSX:DIV
|
CA |
|
C
|
Coolpad Group Ltd
HKEX:2369
|
CN |
|
C
|
Cache Exploration Inc
OTC:CEXPF
|
CA |
|
Z
|
Zhejiang Kaier New Materials Co Ltd
SZSE:300234
|
CN |
|
P
|
Perfect Corp
NYSE:PERF
|
TW |
|
Morinaga & Co Ltd
TSE:2201
|
JP |
|
M
|
Motic Xiamen Electric Group Co Ltd
SZSE:300341
|
CN |
|
P
|
Pioneer Lithium Ltd
ASX:PLN
|
AU |
|
Z
|
Zhejiang Construction Investment Group Co Ltd
SZSE:002761
|
CN |
Bankruptcy Probability
Porton Pharma Solutions Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Porton Pharma Solutions Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CN |
P
|
Porton Pharma Solutions Ltd
SZSE:300363
|
10.6B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Porton Pharma Solutions Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Porton Pharma Solutions Ltd has total debt of 1.4B CNY. This includes both short-term (48.5m CNY) and long-term (1.3B CNY) debt.
You can find a full breakdown on its Balance Sheet.
